Breakout coming soon Price is ready to break 90$ resistance (light blu line) !
A large GAP is also waiting to be filled above 90$
I think everything is ready to push price up
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.26 EUR
556.60 M EUR
3.90 B EUR
386.62 M
About DexCom, Inc.
Sector
Industry
CEO
Kevin Ronald Sayer
Website
Headquarters
San Diego
Founded
1999
FIGI
BBG01TNY8685
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
DXCM DexCom Options Ahead of EarningsAnalyzing the options chain and the chart patterns of DXCM DexCom prior to the earnings report this week,
I would consider purchasing the 90usd strike price Calls with
an expiration date of 2025-2-21,
for a premium of approximately $1.65.
If these options prove to be profitable prior to the earnings
BreakoutPrice finally breaking out of green channel up
A lot of GAPs are waiting to be filled upward
$DXCM - Breaking Out Now! 46% Upside!Chart #20/ 40: NASDAQ:DXCM 🏥
-Symmetrical Triangle Breakout with breakdown Retest
-H5 Indicator is Green
-Williams Consolidation Box Support Created
-AVP Shelf to launch off with Massive VOLUME GAP
🎯$110📏 $91 ⏳ Before APR2025
NFA
DXCM LongLong on Diabetes. Diabetes will only get worse as we continue to eat garbage everyday. Fib level.
DXCM Long Swing Analysis
DXCM offers a compelling swing trade setup, with a strong base forming over the past 4 months around a critical support zone of $74–$68. Following a drop on July 2024 earnings, the stock remains resilient, supported by robust revenue figures and, in my view, a superior CGM product tha
Dexcom Inc. 1. Company Overview and Industry Growth Potential
Dexcom Inc. is a prominent player in the medical technology industry, focusing on continuous glucose monitoring (CGM) systems primarily used by individuals with diabetes. The company's flagship product line, the Dexcom G Series, offers real-time glu
5 Shades of Grey!DXCM 5 shades of grey;
First started in May 2020 when this area of around 107 continues tocomeback whether it be to consolidate, trend, or reverse 3 pivot points found, fast forward to the 2nd shade of grey when in February 2021 the stock came back as a double top.
The 3rd shade started a year a
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
DXCM5195221
DexCom, Inc. 0.25% 15-NOV-2025Yield to maturity
5.89%
Maturity date
Nov 15, 2025
DXCM5813816
DexCom, Inc. 0.375% 15-MAY-2028Yield to maturity
2.78%
Maturity date
May 15, 2028
See all 1DXCM bonds
Related stocks
Frequently Asked Questions
The current price of 1DXCM is 71.54 EUR — it has increased by 14.41% in the past 24 hours. Watch DEXCOM INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange DEXCOM INC stocks are traded under the ticker 1DXCM.
1DXCM stock has risen by 15.52% compared to the previous week, the month change is a 15.52% rise, over the last year DEXCOM INC has showed a 15.52% increase.
We've gathered analysts' opinions on DEXCOM INC future price: according to them, 1DXCM price has a max estimate of 101.88 EUR and a min estimate of 72.65 EUR. Watch 1DXCM chart and read a more detailed DEXCOM INC stock forecast: see what analysts think of DEXCOM INC and suggest that you do with its stocks.
1DXCM reached its all-time high on May 2, 2025 with the price of 71.54 EUR, and its all-time low was 61.58 EUR and was reached on Apr 25, 2025. View more price dynamics on 1DXCM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1DXCM stock is 12.59% volatile and has beta coefficient of 1.26. Track DEXCOM INC stock price on the chart and check out the list of the most volatile stocks — is DEXCOM INC there?
Yes, you can track DEXCOM INC financials in yearly and quarterly reports right on TradingView.
DEXCOM INC is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
1DXCM earnings for the last quarter are 0.30 EUR per share, whereas the estimation was 0.30 EUR resulting in a −2.21% surprise. The estimated earnings for the next quarter are 0.40 EUR per share. See more details about DEXCOM INC earnings.
DEXCOM INC revenue for the last quarter amounts to 957.62 M EUR, despite the estimated figure of 940.44 M EUR. In the next quarter, revenue is expected to reach 995.97 M EUR.
1DXCM net income for the last quarter is 97.43 M EUR, while the quarter before that showed 146.54 M EUR of net income which accounts for −33.52% change. Track more DEXCOM INC financial stats to get the full picture.
No, 1DXCM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 4, 2025, the company has 10.3 K employees. See our rating of the largest employees — is DEXCOM INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DEXCOM INC EBITDA is 792.90 M EUR, and current EBITDA margin is 20.28%. See more stats in DEXCOM INC financial statements.
Like other stocks, 1DXCM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DEXCOM INC stock right from TradingView charts — choose your broker and connect to your account.